Gufic Biosciences (NSE:GUFICBIO) EPS (Basic) : ₹8.17 (TTM As of Dec. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Gufic Biosciences EPS (Basic)?

Gufic Biosciences's basic earnings per share (Basic EPS) for the three months ended in Dec. 2024 was ₹1.93. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹8.17.

Gufic Biosciences's EPS (Diluted) for the three months ended in Dec. 2024 was ₹1.93. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹8.17.

Gufic Biosciences's EPS without NRI for the three months ended in Dec. 2024 was ₹1.93. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was 8.34.

During the past 12 months, Gufic Biosciences's average EPS without NRIGrowth Rate was -3.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was 25.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was 34.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 37.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Gufic Biosciences's highest 3-Year average EPS without NRI Growth Rate was 54.50% per year. The lowest was 20.00% per year. And the median was 35.95% per year.

Gufic Biosciences EPS (Basic) Historical Data

The historical data trend for Gufic Biosciences's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gufic Biosciences EPS (Basic) Chart

Gufic Biosciences Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EPS (Basic)

Get a 7-Day Free Trial

2.34

4.56

9.89

8.22

8.74

Gufic Biosciences Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EPS (Basic)	Get a 7-Day Free Trial															2.23	1.99	2.08	2.17	1.93

Gufic Biosciences EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Gufic Biosciences's Basic EPS for the fiscal year that ended in Mar. 2024 is calculated as

Basic EPS (A: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(861.356	-	0)	/	98.520
	=	8.74

Gufic Biosciences's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(193.052	-	0)	/	100.027
	=	1.93

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹8.17

Gufic Biosciences (NSE:GUFICBIO) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Gufic Biosciences EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Gufic Biosciences's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Gufic Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gufic Biosciences Ltd (NSE:GUFICBIO) » Definitions » EPS (Basic)

Traded in Other Exchanges

509079:India

Address

SM House, 11 Sahakar Road, 1st to 4th Floor, Vile Parle (East), Mumbai, MH, IND, 400 057

Website

https://www.gufic.com

Gufic Biosciences Ltd is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Geographically, it derives a majority of revenue from India. Its product portfolio includes Criticare; Criticare Life; Ferticare; Spark; Herbal and other products. The company's lyophilized product includes antibiotics, anti-fungal, cardiac, infertility, anti-viral and a proton-pump inhibitor. It derives maximum revenue from India.

Gufic Biosciences Headlines

No Headlines